The changing landscape in oncology 

Oncology moves at the speed of science and research, giving rise to new challenges beyond the traditional strategic framework. Today, the business of cancer has shifted to encompass integration of policy, providers, payers, patients, and pharmacies. The demand for value in this complex environment creates the need for innovative paradigms and models that are commensurate with the dynamics of an evolving landscape.

Category expertise to address industry challenges 

We strive to help our clients navigate their most pressing commercialization challenges and business needs. The OBU houses and aggregates a wealth of strategic and clinical practices across solid tumors, hematologic malignancies, and genomics, including immunotherapy and diagnostics. This enables us to extend our clients’ access to relevant insights, influential industry experts, policy implications, and measurable solutions.

Our mission

To develop and leverage proprietary oncology knowledge, experts, and models to optimize commercial value and business outcomes for our clients.

Key Contact

Jeffrey Gruenglas, Executive Vice President